Identification of Critical Transcriptomic Signaling Pathways in Patients with H Syndrome and Rosai-Dorfman Disease

• Published in: Journal of clinical immunology Vol. 41; no. 2; pp. 441 - 457
• Main Authors: Lara-Reyna, Samuel, Poulter, James A., Vasconcelos, Elton J.R., Kacar, Mark, McDermott, Michael F., Tooze, Reuben, Doffinger, Rainer, Savic, Sinisa
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.02.2021; Springer Nature B.V
• Subjects: Adolescent; Adult; Autoimmune Diseases - genetics; Biomarkers - metabolism; Biomedical and Life Sciences; Biomedicine; Contracture - genetics; Cytokines - genetics; Female; Gene expression; Gene Expression - genetics; Hearing Loss, Sensorineural - genetics; Histiocytes - metabolism; Histiocytosis; Histiocytosis - genetics; Histiocytosis, Sinus - genetics; Humans; Immune response; Immunology; Infectious Diseases; Inflammation; Inflammation - genetics; Internal Medicine; Lymph nodes; Lymphadenopathy; Macrophages; Macrophages - metabolism; Male; Medical Microbiology; Middle Aged; Monocytes; Monocytes - metabolism; Nucleoside Transport Proteins - genetics; Original; Original Article; Ribonucleic acid; RNA; Signal transduction; Signal Transduction - genetics; Transcriptome - genetics; Transcriptomics; Tumor necrosis factor; Young Adult; γ-Interferon; systemic autoinflammatory disease; H syndrome; interferon gamma
• ISSN: 0271-9142; 1573-2592
• DOI: 10.1007/s10875-020-00932-1

Biallelic mutations in SLC29A3 cause histiocytosis-lymphadenopathy plus syndrome, also known as H syndrome (HS). HS is a complex disorder, with ~ 25% of patients developing autoinflammatory complications consisting of unexplained fevers, persistently elevated inflammatory markers, and unusual lymphadenopathies, with infiltrating CD68 + , S100 + , and CD1a − histiocytes, resembling the immunophenotype found in Rosai-Dorfman disease (RDD) . We investigated the transcriptomic profiles of monocytes, non-activated (M0), classically activated (M1), and alternatively activated macrophages (M2) in two patients with HS, one without autoinflammatory (HS1) and one with autoinflammatory complications (HS2). RNA sequencing revealed a dysregulated transcriptomic profile in both HS patients compared to healthy controls (HC). HS2, when compared to HS1, had several differentially expressed genes, including genes associated with lymphocytic-histiocytic predominance (e.g. NINL ) and chronic immune activation (e.g. B2M ). The transcriptomic and cytokine profiles of HS patients were comparable to patients with SAID with high levels of TNF. SERPINA1 gene expression was found to be upregulated in all patients studied. Moreover, higher levels of IFNγ were found in the serum of both HS patients when compared to HC. Gene ontology (GO) enrichment analysis of the DEGs in HS patients revealed the terms “type I IFN,” “IFNγ signaling pathway,” and “immune responses” as the top 3 most significant terms for monocytes. Gene expression analysis of lymph node biopsies from sporadic and H syndrome-associated RDD suggests common underlying pathological process . In conclusion, monocytes and macrophages from both HS patients showed transcriptomic profiles similar to SAIDs and also uniquely upregulated IFNγ signature. These findings may help find better therapeutic options for this rare disorder.